ArticleStat2022
Multilevel Varying Coefficient Spatiotemporal Model.
Article in Stat, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multivariate varying coefficient spatiotemporal model.Statistics in biosciences · 2024Article
- Spatiotemporal multilevel joint modeling of longitudinal and survival outcomes in end-stage kidney disease.Lifetime data analysis · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Over 785,000 individuals in the U.S. have end-stage renal disease (ESRD) with about 70% of patients on dialysis, a life-sustaining treatment. Dialysis patients experience frequent hospitalizations. In order to identify risk factors of hospitalizations, we utilize data from the large national database, United States Renal Data System (USRDS). To account for the hierarchical structure of the data, with longitudinal hospitalization rates nested in dialysis facilities and dialysis facilities nested in geographic regions across the U.S., we propose a multilevel varying coefficient spatiotemporal model (M-VCSM) where region- and facility-specific random deviations are modeled through a multilevel Karhunen-Loéve (KL) expansion. The proposed M-VCSM includes time-varying effects of multilevel risk factors at the region- (e.g., urbanicity and area deprivation index) and facility-levels (e.g., patient demographic makeup) and incorporates spatial correlations across regions via a conditional autoregressive (CAR) structure. Efficient estimation and inference is achieved through the fusion of functional principal component analysis (FPCA) and Markov Chain Monte Carlo (MCMC). Applications to the USRDS data highlight significant region- and facility-level risk factors of hospitalizations and characterize time periods and spatial locations with elevated hospitalization risk. Finite sample performance of the proposed methodology is studied through simulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.